10x Genomics Inc (TXG)
26.44
-0.81
(-2.97%)
USD |
NASDAQ |
May 07, 16:00
26.44
0.00 (0.00%)
After-Hours: 16:38
10x Genomics Revenue (Quarterly): 141.01M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 141.01M |
December 31, 2023 | 183.98M |
September 30, 2023 | 153.64M |
June 30, 2023 | 146.82M |
March 31, 2023 | 134.28M |
December 31, 2022 | 156.23M |
September 30, 2022 | 131.07M |
June 30, 2022 | 114.61M |
March 31, 2022 | 114.50M |
December 31, 2021 | 143.53M |
September 30, 2021 | 125.30M |
June 30, 2021 | 115.84M |
Date | Value |
---|---|
March 31, 2021 | 105.82M |
December 31, 2020 | 112.22M |
September 30, 2020 | 71.82M |
June 30, 2020 | 42.90M |
March 31, 2020 | 71.90M |
December 31, 2019 | 75.29M |
September 30, 2019 | 61.21M |
June 30, 2019 | 55.82M |
March 31, 2019 | 53.58M |
December 31, 2018 | 50.55M |
September 30, 2018 | 36.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
42.90M
Minimum
Jun 2020
183.98M
Maximum
Dec 2023
112.89M
Average
115.23M
Median
Revenue (Quarterly) Benchmarks
Teladoc Health Inc | 646.13M |
American Shared Hospital Services | 5.698M |
Novo Integrated Sciences Inc | 3.171M |
Astrana Health Inc | 353.04M |
Cryo-Cell International Inc | 7.852M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -59.95M |
Total Expenses (Quarterly) | 202.50M |
EPS Diluted (Quarterly) | -0.50 |
Enterprise Value | 2.890B |
Gross Profit Margin (Quarterly) | 65.89% |
Profit Margin (Quarterly) | -42.52% |
Earnings Yield | -8.43% |
Normalized Earnings Yield | -8.434 |